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Background: Major Depressive Disorder (MDD), a life-threatening psychiatric illness, is 
the most significant global cause of disability, with approximately 300 million people affected 
(Maurer, Raymond, & Davis, 2018). When the signs and symptoms are unrecognized or left 
untreated, MDD increases the risk of medical comorbidities, particularly heart disease, stroke, 
Alzheimer’s disease, obesity, and diabetes (Maurer, Raymond, & Davis, 2018). Untreated MDD 
also increased the risk of suicide by 0.5-4% compared to the general population, and completed 
suicides are the 10th leading cause of death in the United States (Maurer, Raymond, & Davis, 
2018). 
Objective: To assist a midsize patient-centered medical home (PCMH) in North Carolina 
to integrate and sustain a standardized screening protocol for MDD using the PHQ-9. 
Methods: Develop a standardized depression screening protocol algorithm to initiate 
depression screening in a primary care practice. Measure rate of screening by each provider 
involved in the project and determine if the subsequent management of the patient with a positive 
screen was appropriate. Determine if provider satisfaction increased with a standardized protocol 
for depression screening. 
Results: During this quality improvement project, 65 adults aged 18-65, were assessed for 
the signs and symptoms of depression using the PHQ-9. A total of 107 patients fit the inclusion 
criteria for a screening rate of 60.74%. As a result of this screening, 3 patients scored at or above  
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the threshold of 10 on the PHQ-9 screening tool and adherence to the implemented protocol was 
observed. Screening rates for patients between the ages of 18-65 attending either a new patient or 
yearly physical appointment, approximately 17% of the total patient population at this primary 
care practice, increased from 1.59% to 60.49%.  All three providers that participated in the project 
acknowledged that their satisfaction with depression screening improved. 
Conclusion: This quality improvement project has shown that implementing a depression 
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CHAPTER 1: INTRODUCTION 
Major Depressive Disorder (MDD), a life-threatening psychiatric illness, is the 
most significant global cause of disability, with approximately 300 million people affected 
(Maurer, Raymond, & Davis, 2018). More than 16 million American adults met the criteria for at 
least one episode of MDD in the last 12 months (Ferenchick, Ramanuj, & Pincus, 2019; Maurer, 
Raymond, & Davis, 2018). When the signs and symptoms are unrecognized or left untreated, 
MDD increases the risk of medical comorbidities, particularly heart disease, stroke, Alzheimer’s 
disease, obesity, and diabetes (Maurer, Raymond, & Davis, 2018). MDD is not only a severe 
public health problem; it is the most frequent psychiatric disorder reported in the adult 
population, with a lifetime prevalence of 20.6% in the United States (Hasin et al., 2018). MDD 
accounts for approximately 210 billion dollars in healthcare spending per year, which continues 
to increase annually (Maurer, Raymond, & Davis, 2018). 
Untreated MDD also increased the risk of suicide by 0.5-4% compared to the general 
population, and completed suicides are the 10th leading cause of death in the United States 
(Maurer, Raymond, & Davis, 2018). In 2014, suicide rates continued to rise in the United States, 
with over 40,000 deaths from suicide secondary to a diagnosis of depressive disorder (Smithson 
& Pignone, 2017). During 2016, approximately 45,000 people died by suicide nationwide, with 
significant increases in suicide rates in almost every state (Stone et al., 2018). About 50% of 
completed suicides in adults followed a visit to a primary care physician within the last 30 days 
(Ferenchick, Ramanuj, & Pincus, 2019). Primary care visits are the most common type of 
healthcare visit before death, with 75% in the previous year and approximately 45% in the last  
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month (Jordan, Shedden-Mora, & Löwe, 2018). 
Screening for MDD in a primary care setting is a logical, cost-effective plan of action to 
mitigate this public health crisis. The 9-item Patient Health Questionnaire (PHQ-9) (Appendix 
A) is a valid and reliable screening tool that objectifies and assesses the extent of depression
severity, and has been successfully administered in primary care environments for the past 18 
years (Ferenchick, Ramanuj, & Pincus, 2019; Levis, Benedetti, Thombs, & The DEPRESSD 
Collaboration, 2019). The PHQ-9 is self-administered, quickly scored, and has been extensively 
researched with consistent findings (Kroenke, Spitzer, & Williams, 2001). Screening all adults in 
the primary care setting for depression helps to meet the criteria for a Patient-Centered Medical 
Home (PCMH) and works towards achieving the Quadruple Aim of healthcare (Sandoval, Bell, 
Khatri, Robinson, 2018). The U.S. Preventative Services Task Force (USPSTF), The American 
Academy of Family Physicians, The American College of Preventative Medicine, and The 
Institute for Clinical Systems Improvement all recommend regular screening for depression in 
primary care for adults (Maurer, Raymond, & Davis, 2018; Siu & and the US Preventative Task 
Force (USPSTF), 2016; Trangle et al., 2016).  Despite these recommendations, the rate of 
screening for depressive symptoms in primary care remains less than 2% (Akincigil & Matthews, 
2017). 
Problem Statement 
Access to screening for MDD is limited, despite healthcare policy aimed at increasing 
coverage and engagement with mental health care professionals. As a result, those with MDD are 
not obtaining the appropriate screening and management in primary care, which has led to a 
public health crisis (Jones et al. 2017). Research and recommendations by multiple professional 
organizations have identified primary care as an appropriate location for utilization of screening  
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for MDD; however, primary care settings face barriers to implementation. 
Local Context 
Similar to national trends, North Carolina’s primary care practices have also struggled 
with the planning and implementation of standardized screening protocols for MDD (Christian, 
Krall, Hulkower, & Stigleman, 2018). Although behavioral health integration is identified as a 
best practice, some primary care settings in NC have not been able to implement the screening 
tools that can increase the recognition, assessment, and management of common mental health 
disorders. Many clinicians have reported that behavioral health integration is expensive, difficult 
to sustain, and, subsequently, it is often avoided (Christian, Krall, Hulkower, & Stigleman, 
2018). Primary care providers relate that they have limited knowledge and skill in the follow-up 
assessment and management of MDD (Waitzfelder et al., 2018). In reality, screening, evaluation, 
and management of MDD in primary care is a less expensive way to address this public health 
crisis. Standardized screening for MDD in primary care is also a gateway to achieve and 
maintain the distinction of a Patient-Centered Medical Home (PCMH) (Christian, Krall, & 
Stigleman, 2018). 
Purpose Statement 
The purpose of this quality improvement (QI) project was to assist a midsize patient-
centered medical home (PCMH) in North Carolina and to integrate and sustain a standardized 
screening protocol for MDD using the PHQ-9. Outcome measures include fidelity of the 
screening protocol, including the number of positive screens compared to baseline. Outcome 
measures also include patient outcomes, including determining if appropriate management of the 
patient with a positive screen was initiated. In addition to identifying the barriers to using the 
PHQ-9 screening tool, this project also identified the needs and concerns of the health care  
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providers as they navigate this process in the workflow. Data regarding improved provider 
satisfaction was gathered by the administration of a survey before and after implementation of 
the screening and management protocol. Improved provider satisfaction and improved patient 
outcomes are two of the four critical results of the Quadruple Aim (Sandoval, Bell, Khatri, 
Robinson, 2018). 
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CHAPTER 2: REVIEW OF LITERATURE 
This review of literature focuses on articles that were published between 2015 and 2019 
and also includes a hallmark study published in 2001 that depicts the development of the PHQ-9. 
Databases used included PubMed, CINAHL, and PsycINFO. The search terms used were “Care, 
Primary Health” OR “Health Care, Primary” OR “Primary Healthcare” OR “Healthcare, 
Primary” OR “Primary Care” OR “Care, Primary” OR "primary health care" OR “Physician, 
Primary Care” OR “Primary Care Physician” OR “Primary Care Physicians”  AND "depressive 
disorder, major" OR "depressive disorder" OR “major depressive disorder” OR "depression" OR 
“depression”  AND “Patient Health Questionnaire 9” OR “PHQ-9” OR “PHQ Patient Health 
Questionnaire” OR “Primary Care Evaluation of Mental Disorders”. The initial search yielded 
1,896 articles related to Major Depressive Disorder (MDD) and the Patient Health 
Questionnaire-9 (PHQ-9) in primary care. Limiters used in this literature search include articles 
written in English and only focused on adult patients ages 18 to 65. After analyzing the first 
1,896 articles, and removing duplicates, the compilation was narrowed down to 23 articles which 
focus on the use of the PHQ-9 in primary care, relevant barriers associated with the use of the 
PHQ-9, and recommendations for implementing the PHQ-9. This literature review will present 
and discuss the following subsections: (a) history, validity, and reliability of the PHQ-9; (b) 
recommendations for the use of the PHQ-9; (c) barriers to implementation of standardized 
depression screening in primary care; and (d) consequences of unrecognized or untreated 
depression in primary care. 
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History, Validity, and Reliability 
The use of the PHQ-9 as a screening tool for MDD has been extensively tested and 
established as a valid and reliable tool (Kroenke, Spitzer, & Williams, 2001). The PHQ-9 is used 
for recognizing the presence and severity of symptoms of depression in primary care settings in 
the United States (Kroenke, Spitzer, & Williams, 2001). In 2001, a hallmark study in the United 
States involving 6,000 patients, determined that the PHQ-9 had both sensitivity and specificity of 
88% when using a threshold of 10 or higher (Kroenke, Spitzer, & Williams, 2001). In this study, 
the internal reliability of the PHQ-9 in primary care was a Cronbach’s α of 0.89, and the area 
under the curve (AUC) of the PHQ-9 was 0.95 (Kroenke, Spitzer, & Williams, 2001). In 2016, a 
meta-analysis was conducted of 40 studies and found the overall sensitivity of the PHQ-9 was 
“81.3% (95% CI, 71.6-89.3)” and an overall specificity of “85.3% (95% CI, 81.0-89.1)” 
(Mitchell, Vadegarfar, Gill, & Stubbs, 2016). The results of these studies demonstrated that the 
PHQ-9 was not a diagnostic instrument but rather a screening tool to be used to identify the 
signs, symptoms, and severity of MDD (Mitchell, Vadegarfar, Gill, & Stubbs, 2016).  
Several countries in Europe, including Spain and Latvia, and Asian countries, including 
Japan, have also tested the validity and reliability of the PHQ-9 in primary care. These countries, 
however, have more variability in the cutoff points between mild and moderate depression. Two 
studies in Latvia reported on the validity of the PHQ-9 in primary care using cutoff points of 8 
and 10. These studies found the sensitivity of the PHQ-9 to be 75%-86.5%, specificity to be 
79%-89%, and Cronbach’s α to be 0.81-0.84, respectively (Rancans, Trapencieris, Ivanovs, & 
Vrublevska, 2018; Vrublevska, Trapencieris, & Rancans, 2018). In Spain, a study was conducted 
comparing two cutoff points of 10 and 12 and the subsequent effect on reliability. These 
researchers found a sensitivity of 0.95-0.84 and specificity of 0.67-0.78, respectively (Muñoz- 
7 
Navarro et al., 2017). Studies conducted in Japan used cutoff points 10 and 11, yielding a 
sensitivity of 90.5%-76% and specificity of 76.6%-81%, respectively (Muramatsu et al., 2018; 
Suzuki, Kumei, Ohhira, Nozu, Okumura, 2015).  
The PHQ-9 has also shown to be valid and reliable when screening patients with 
comorbid medical diseases and illnesses such as diabetes, coronary heart disease, HIV, and 
hypertension. According to Trangle et al., (2016), there is research that found that the PHQ-9 is a 
better tool for assessing depression in patients who have other chronic conditions. A study using 
the PHQ-9 on patients with comorbid diabetes found that at a cutoff point of 10 or higher, 
Cronbach’s α was 0.87 for patients with diabetes and 0.82 for patients without diabetes (Janssen 
et al., 2016). Another study screened for depression in patients with comorbid coronary heart 
disease (CHD) using a cutoff of 10 or higher, found a “sensitivity of 84%, a specificity of 82%, 
and AUC of 0.88” (Van der Zwaan et al., 2016). Finally, patients with comorbid HIV and 
hypertension found that at a cutoff of 9, sensitivity was 51%, specificity was 94%, and the area 
under the curve (AUC) was 0.85 and 0.86, respectively (Bhana, Rathod, Selohilwe, Kathree, & 
Petersen, 2015). Collectively, these studies demonstrate the strength of the PHQ-9 screening tool 
for depression alone and in conjunction with comorbid illnesses. 
Recommendations for Use 
The U.S. Preventative Services Task Force (USPSTF) and the American College of 
Physicians recommend screening for depression in primary care (Siu & and the US Preventative 
Task Force (USPSTF), 2016; O’Conner et al., 2016; Crowley & Kirschner, 2015). The American 
College of Preventative Medicine and The Institute for Clinical Systems Improvement also 
recommended screening for depression in primary care for adults who have not already been 
screened or during routine visits (Maurer, Raymond, & Davis, 2018; Trangle et al., 2016). While 
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 these institutions recommend screening for depression in primary care, they do not outline 
screening intervals or the use of a particular screening tool (Maurer, Raymond, & Davis, 2018). 
The use of the PHQ-9 as a screening instrument has been recommended based on a meta-
analysis of 40 studies (Mitchell, Vadegarfar, Gill, & Stubbs, 2016).  
Barriers  
There are several barriers to primary care settings implementing the PHQ-9 cited in the 
literature. These barriers include lack of time to implement and score the PHQ-9, lack of 
provider education and comfort using the screening tool, and patient resistance to completing the 
PHQ-9 (Waitzfelder et al., 2018). Willborn et al. (2016) found that the PHQ-9 guidelines for use 
were not clear, and despite the need for identification of depressive symptoms and severity of 
symptoms, they postulate that there are no known consequences for not screening for depression. 
Many providers have also identified concern for using a screening tool that identifies depressive 
symptoms when they are unable or uncomfortable initiating and managing treatment options. 
Other barriers include billing codes and reimbursement, as well as difficulty implementing or 
integrating screening into the current workflow (Akincigil & Matthews, 2017). In a study aimed 
at examining the use of the PHQ-9 for screening in patients with diabetes, patients who already 
carried the diagnosis of MDD were much more likely to be screened using the PHQ-9 than 
patients without a prior diagnosis of depression (Barnacle, Strand, Werremeyer, Maack, & Petry, 
2016). These findings suggest clinicians used the tool to manage the symptoms rather than to 
screen for depression and severity in patients.  
Consequences of Unrecognized Depression in Primary Care 
There are many unfortunate consequences of unrecognized MDD in primary care. While 
the U.S. Preventative Services Task Force (USPSTF) decided that there was inadequate evidence 
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to screen specifically for suicidality in adults in a primary care setting, suicide has been linked to 
MDD and is included as a question on the PHQ-9 (Siu & and the US Preventative Task Force 
(USPSTF), 2016). Increased severity of depression, as determined by screening using the PHQ-
9, is associated with an increased risk of suicide (Ferenchick, Ramanuj, & Pincus, 2019). 
Ferenchick, Ramanuj, & Pincus (2019) also found that almost 50% of those who completed 
suicide had a primary care visit inside the last month before their death. Unrecognized 
depression in the primary care setting can increase the risk of suicide, which necessitates 
screening with the PHQ-9, as it includes suicidal ideation.   
Unrecognized and untreated MDD can also exacerbate comorbid chronic medical 
conditions and lead to decreased patient outcomes and increased mortality. In particular, 
comorbid cardiovascular disease (CVD), heart failure, and coronary heart disease (CHD) are 
associated with worsening outcomes secondary to unrecognized depression. Comorbid CHD, 
diabetes, and depression led to an increased risk of mortality and decreased quality of life (Van 
der Zwaan et al., 2016). A study in a Latvian primary care clinic found that patients with MDD 
were 2.08 times more likely to have comorbid CVD (Ivanovs, Kivite, Ziedonis, Mintale, 
Vrublevska, & Rancans, 2018). In a study of 425 patients, those with depression and heart failure 
were 2.02 times more likely to die and 1.42 times more likely to be hospitalized for cardiac 
complications (Jani, Mair, Roger, Weston, Jiang, Chamberlain, 2016). Screening for MDD with 
the PHQ-9 in the primary care setting can improve outcomes for patients who also suffer from 
cardiovascular disease (Ivanovs, Kivite, Ziedonis, Mintale, Vrublevska, & Rancans, 2018; Jani, 
Mair, Roger, Weston, Jiang, Chamberlain, 2016). 
Summary and Application 
The PHQ-9 is a valid and reliable tool for the screening and severity rating of MDD in a 
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primary care setting (Ferenchick, Ramanuj, & Pincus, 2019; Levis, Benedetti, Thombs, & 
The DEPRESSD Collaboration, 2019; Kroenke, Spitzer, & Williams, 2001). Numerous studies 
have shown that the PHQ-9 has high sensitivity and specificity at a threshold of 10 or greater, 
indicating moderate to severe depression. Although various professional associations, including 
the U.S. Preventative Services Task Force (USPSTF), advocate for the use of screening for 
depression in primary care, screening rates remain low because of the barriers presented. The 
benefit of using the PHQ-9 for screening for MDD in primary care far outweighs the risk. 
Primary care providers should be encouraged to utilize this tool to identify patients who could 
take advantage of the treatment of MDD to improve patient outcomes.   
This literature review demonstrates that the PHQ-9 is a valid and reliable tool that needs 
to be used to screen for MDD in a primary care setting to mitigate the public health crisis that the 
US is experiencing. Education and a standardized screening protocol based on evidence-based 
research can improve primary care providers' utilization of the PHQ-9 to screen for the presence 
and severity of MDD. Screening using the PHQ-9 would lead to early recognition, potentially 
swift treatment, and ongoing management of MDD in primary care. 
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CHAPTER 3: THEORETICAL FRAMEWORK 
The implementation of a standardized screening protocol for Major Depressive Disorder 
(MDD) using the PHQ-9 in primary care requires a model of change that will guide the project
and ensure sustainability. Lippitt’s Change Theory (Appendix B), developed in 1958 as an 
extension of Lewin’s Theory of Change, outlines a detailed plan for initiating change in an 
organization (Lippitt, Watson, & Westley, 1958). Lippitt’s Change Theory has been proven in 
the field of healthcare and is frequently used in nursing because it fits in parallel with the 
“nursing process elements of assessment, planning, implementation, and evaluation” (Mitchell, 
2013). Most change theories focus on the change implemented or the organization where the 
change will take place. Lippitt, however, focuses on the people who will be affected by the 
change and the person who will implement the change, the change agent (Wagner, 2018). 
“Lippitt’s Change Theory separates into seven phases: 
1. Diagnose the problem
2. Assess motivation and capacity for change
3. Assess change agent’s motivation and resources
4. Select progressive change objective
5. Choose the role of the change agent
6. Maintain change
7. Terminate the helping relationship.”
(Lippitt, Watson, & Westley, 1958; Mitchell, 2013). 
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This proposal, particularly the review of literature, serves as the first phase of Lippitt’s 
Change Theory. This proposal has identified several possible “diagnoses” or problems that may 
influence or impact the introduction of a screening tool for depression to primary care practices. 
The problem is that barriers to screening for MDD using the PHQ-9 in primary care prevent the 
systematic use of a screening protocol and can harm patient outcomes. For phase two, the focus 
will be to assess the identified primary care practice’s level of motivation to implement screening 
tools such as the PHQ-9, improve patient outcomes, and continue to meet the requirements for a 
Patient-Centered Medical Home (PCMH). In phase three, an external change agent was 
identified as the graduate student facilitating this process. As the change agent, I assisted this 
practice to serve their patients better by using the ample resources at my disposal for completing 
this project. This proposal also served as phase four of Lippitt’s Change Theory in which a 
detailed plan was developed to outline implementation. Phases five through seven of Lippitt’s 
Change Theory took place throughout the actual implementation of the project. 
In combination with Lippitt’s Change Theory, this project will also use The Model for 
Improvement (Appendix C), which was developed by The Associates in Process Improvements 
and used by the Institute of Healthcare Improvement (IHI) (Silver et al., 2016). This proposal 
served as the answers to the first three questions of The Model for Improvement, “what are we 
trying to accomplish?”, “How will we know a change is an improvement?” and “what changes 
can we make that will result in improvement?” (Langley et al., 2009). The final phases of 
Lippitt’s Change Theory took place during the implementation of the project, and were guided 
by the Plan, Do, Study, Act (PDSA) cycles of the Model for Improvement (Langley et al., 2009). 
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CHAPTER 4: METHODS 
This quality improvement (QI) project was designed to create a standardized depression 
screening protocol for adults ages 18-65 in a primary care setting using the PHQ-9. Quantitative 
data was collected from compliance rates to measure fidelity, which was calculated by 
comparing the number of positive screens to baseline. Data regarding the management of the 
patient with a positive screen was also collected, as well as provider surveys used to determine if 
the protocol increased provider satisfaction (appendix D; appendix G). This project focused on 
the implementation of the PHQ-9 as a standard depression screening protocol for adult patients, 
ages 18-65, that were new to the practice or obtaining their yearly physical. 
Context 
The primary care practice in which this project was conducted reported challenges with 
implementing a depression screening protocol because of time constraints and lack of buy-in 
from staff. Before the project implementation of this depression screening protocol, the providers 
at this practice only used depression screening tools on patients who verbalized depressive 
symptoms to determine severity. The patients were given the PHQ-9 screening tool to be 
completed in front of the provider during that visit. On observation, the lack of a standardized 
depression screening protocol led to a gap in care in which patients who may be positive for 
depressive symptoms were not being adequately screened, assessed, and managed. Provider 
reports from the surveys conducted, indicated that screening for depression during the 
appointment mentioned above had led to time constraints and frustration towards a consistent 
screening protocol. Therefore, this standardized depression screening protocol aided this primary 
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care practice by maximizing time and increasing the opportunity to address underlying MDD in 
their adult patient population. 
Process  
This project implemented a standardized screening protocol for depression, using the 
PHQ-9, to determine the presence of symptoms, and if present, the severity of MDD (Kroenke, 
Spitzer, & Williams, 2001). All adult patients ages 18-65, at an appointment as a new patient or 
obtaining a yearly physical, were screened using the PHQ-9. Patients were handed the PHQ-9 by 
the triage staff who took the patient to the examination room, to be filled out by the patient while 
waiting for the provider. The PHQ-9 was collected and scored by the provider, who also 
conducted a verbal assessment to ensure the appropriate score was obtained. Once the provider 
had a patient that scored positively on the PHQ-9, the provider was guided to use the depression 
screening protocol to determine the necessary next steps in management. The outcome of 
positive scores was discussed between the patient and the provider, and patient-centered 
management choices were presented as options for the patient to consider. These options 
included but were not limited to a medical workup, including lab work, medications, specialty 
referral, or emergency transport for acute safety concerns. PHQ-9 score and management 
decisions were documented in the EMR by the provider as well as any follow-up interventions.  
Setting and Population 
This study was conducted in a private primary care practice in North Carolina, which is 
distinguished as a Patient-Centered Medical Home (PCMH). A PCMH delivers patient-centered 
care by a multidisciplinary team that is accessible and focused on improved patient outcomes 
(Sandoval, Bell, Khatri, & Robinson, 2018). Primary care practices within the United States have 
obtained the PCMH distinction as a means of meeting the goals of the IHI’s Triple Aim and,  
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subsequently, the IHI’s improved Quadruple Aim (Sandoval, Bell, Khatri, & Robinson, 2018). 
Maintaining this designation requires primary care providers to use screening tools to assess 
possible underlying common mental illnesses, such as depression, in their patient population as a 
means to provide patient-centered care. Individuals who seek care at this practice primarily use 
private insurance, with a small proportion of self-pay and Medicare patients. During the time of 
the project, this practice did not accept Medicaid patients. This practice employs two full-time 
family nurse practitioners, two part-time family nurse practitioners, one family physician, and 
various ancillary staff members.   
Data Collection Instruments  
The screening tool used to implement the standardized screening protocol in this primary 
care practice was the PHQ-9 (Kroenke, Spitzer, & Williams, 2001). O’Byrne & Jacob (2018), 
found that the PHQ-9 had the most research and the best performance based on a systematic 
review of over 50 screening tools for depression. The PHQ-9 shows sensitivity and specificity of 
88% at a threshold of 10 or higher (Mitchell, Yadegarfar, Gill & Stubbs, 2016). Data collected 
from the PHQ-9 screening and the EMR, included the percentage of positive and negative scores, 
the rate of patients screened, and the interventions used with positive scores.  
Providers participated in a pre-project and post-project survey, using Likert scales and 
open form questions, regarding their ability to recognize symptoms and severity of MDD, 
comfort in further assessment, and comfort initiating treatment once MDD is recognized. 
Provider satisfaction, as it relates to being able to treat those with comorbid mental illnesses such 
as depression, was also assessed. This survey was developed by the graduate student that 
implemented the project, and data was gathered using Qualtrics.  
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Procedures for Project Implementation 
Pre-intervention. 
A pre-project survey was administered to the providers who agreed to participate in this 
project before the implementation of the first PDSA cycle (Appendix D). With this survey, 
educational needs were assessed, and the graduate student provided educational sessions to 
providers on an as-needed basis. These educational sessions were used to address any gaps in 
knowledge identified in the survey. Providers were offered resources to promote the practice 
change process (Appendix E), which included information about various types of antidepressant 
medications and possible side effects to help guide providers if a medication was warranted 
based on PHQ-9 and patient preference (LeBlanc et al., 2016). A protocol was given to the 
providers to use as a guide to decision making based on scores on the PHQ-9 (Appendix F). This 
protocol was developed by the DNP student and the practice champion and was informed by the 
Institute for Clinical Systems Improvement Health Care Guideline (Trangle et al., 2016). The 
cutoff point of 10, which served as the point in which providers must intervene, is the evidence-
based cutoff point indicative of a moderate level of depression (Levis, Benedetti, & Thombs, 
2019; Kroenke, Spitzer, & Williams, 2001). Providers were instructed on this protocol to follow-
up on positive scores with a verbal assessment of mood and suicidality to ensure that a diagnosis 
was not made solely based on PHQ-9 results (Ferenchick, Ramanuj, & Pincus, 2019). This 
verbal assessment was also used to ensure that any false positive scores were ruled out to avoid 
overtreatment and a subsequent increase in healthcare spending (Levis, Benedetti, & Thombs, 
2019). The practice protocol for suicidality was discussed and included in the standardized 
depression screening protocol.  
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Intervention. 
The implementation phase of this project involved two PDSA cycles intending to have 
providers use the PHQ-9 screening tool on every new patient or patient attending their yearly 
physical appointment. In the first PDSA cycle, the implementation of the PHQ-9 took place with 
one provider, the project champion. The provider scored each PHQ-9 questionnaire, and a verbal 
assessment was completed; then, based on the score, the provider and patient determined how to 
proceed. All scores greater than or equal to 10, which suggest a moderate to severe depression, 
were investigated further by the provider to determine the need for treatment. The provider then 
used the US Preventative Services Task Force (USPSTF) evidence-based practice guidelines to 
determine the necessary next steps, including the possibility of additional lab work to rule out 
organic causes, initiation of medication, or the need for specialty referral (Siu & and the US 
Preventative Task Force (USPSTF), 2016). The first PDSA cycle lasted for three weeks and was 
then was analyzed for one week. There were no unanticipated problems or concerns to be 
addressed from the first PDSA cycle to the second PDSA cycle. Several different types of data 
were collected, including compliance rate to determine fidelity, determination of positive versus 
negative scores, and interventions provided to the patients with positive scores.  
The second PDSA cycle included the implementation of the PHQ-9 screening on every 
new patient or patient attending their yearly physical appointment, with the addition of two of the 
part-time FNP’s in the practice. The second PDSA cycle lasted for three weeks and then was 
analyzed for over two weeks.  
Post-Intervention. 
After the two PDSA cycles were completed, data collected from completed patient 
screens, provider pre-project surveys, and the EMR were analyzed, and providers were given a 
post-project survey. The survey was used to determine if the standardized implementation of the 
PHQ-9 for the detection of MDD increased their knowledge and comfort in treating depression 
within primary care. This survey also included a question to determine the likelihood of 
continuation and sustainability of using the PHQ-9 as a standardized screening tool for MDD  
(Appendix G).  
Key personnel/Stakeholders  
This practice consists of one family physician, two full-time family nurse practitioners, 
and two part-time family nurse practitioners, comprising the majority of the stakeholders 
involved in this project. This practice is co-owned by one of the full-time family nurse 
practitioner (FNP) and project champion and the full-time family practice physician. Three of the 
five providers were willing to participate in this project, all of which were family nurse 
practitioners. The part-time FNP that did not participate, refused to complete the pre-project 
survey and was not open to discussion with the graduate student. The family private physician 
was resistant to change and quickly approaching her retirement. The physician did not interfere 
with the project but also refused to complete the pre-project survey or to implement a depression 
screening protocol.   
Evaluation (Data Analysis)  
Quantitative data were derived by gathering compliance rates by collecting the number of 
screening tools completed, divided by the number of eligible patient visits to determine fidelity. 
Data were collected before implementation of the project and at the end of each PDSA cycle and 
were compared. Patient outcome data were obtained by collecting the positive screening rate, or 
the number of positive screens divided by the number of patients screened. Patient outcome data 
were also obtained by collecting the number of patients who were appropriately managed using 
the depression screening protocol. Quantitative patient outcome data were presented with 
descriptive statistics due to the small sample size. Data were obtained from surveys administered  
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pre-project and post-project to the providers who took part in the project, and the results were 
compared to assess for increased knowledge, comfort, and satisfaction of using a standardized 
screening protocol for depression. Graphical representations of all data were produced for 
visualization of project outcomes (figures 1-7).  
Ethics and Human Subjects Permissions  
This quality improvement project was deemed exempt on July 22, 2019, by the UNC-
Chapel Hill Institutional Review Board (IRB) (Appendix H). 
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CHAPTER 5: RESULTS 
During this quality improvement project, 65 adults aged 18-65, were assessed for 
evidence of depression using the PHQ-9 (Kroenke, Spitzer, & Williams, 2001). A total of 107 
patients fit the inclusion criteria for screening for a screening rate of 60.74%. As a result of 
screening, 3 patients scored at or above the threshold of 10 on the PHQ-9 screening tool, and 
adherence to the implemented protocol was observed. Demographic data were gathered over the 
three weeks before implementation and are presented in Figure 1-Figure 3. Of the demographic 
population, 68.25% were female, 68.25% were Caucasian, and 49.20% were between the ages of 
42-57 (Table 1).
Table 1. Population demographics 
Sex Count Percentage 
Female 43 68.25% 
Male 20 31.75% 
Race 
Caucasian 43 68.25% 
African American 11 17.46% 
Asian 4 6.35% 
Pacific Islander 3 4.76% 
Refused 1 1.59% 
Hispanic 1 1.59% 
Age 
18-25 6 9.52% 
26-33 9 14.29% 
34-41 8 12.70% 
42-49 16 25.40% 
50-57 15 23.81% 
58-65 9 14.29% 
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Akincigil & Matthews, (2017), reported similar findings with females representing 63.5% and 
Caucasian representing 71.0% of the sample population. This study, however, also found that 
screening rates were not consistent between sex, race, and age, and also found less participation 
in primary care practices which did not have an electronic health record (Akincigil & Matthews, 
2017). Screening rates in this QI project did not find any variance in sex, race, or age on 
screening for depression (Table 2).  
Table 2. DNP project screening demographics 
Sex Count Percentage 
Female 45 70.31% 
Male 19 29.69% 
Race 
Caucasian 41 64.06% 
African American 11 17.19% 
Asian 7 10.94% 
Pacific Islander 2 3.13% 
Hispanic 2 3.13% 
Refused 1 1.56% 
Age 
18-25 2 3.13% 
26-33 6 9.38% 
34-41 9 14.06% 
42-49 13 20.31% 
50-57 20 31.25% 
58-65 14 21.88% 
These results are widely representative of the demographics in the town in which this project was 
conducted. Data was gathered before the implementation of the screening protocol to determine 
the initial rate of screening for depression. During this time, 63 patients fit inclusion criteria, and 
one patient was screened at a rate of 1.59%. The first PDSA cycle involved implementation of 
the depression screening protocol with one provider, 26 patients fit inclusion criteria, 15 were 
screened, at a rate of 57.69% (Figure 4). The second PDSA cycle implemented the depression  
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screening protocol with three providers; 81 patients fit inclusion criteria, 49 patients were 
screened correctly, at a rate of 60.49% (Figure 5). Provider one, which participated in both 
PDSA cycles, showed a consistent increase in the percentage of patients screened (Figure 6). 
Screening rates for patients between the ages of 18-65 attending either a new patient or yearly 
physical appointment, approximately 17% of the total patient population at this primary care 
practice, increased from 1.59% to 60.49% (Table 3, Figure 7).  
Although only 3 patients scored a positive score above 10, those patients were treated 
appropriately by all three providers engaged in this project. The patient who scored a 10 on the 
PHQ-9 screening tool was restarted on psychotropic medication and scheduled for a follow-up in 
two weeks. The patient who scored a 15 on the PHQ-9 screening tool was referred to a 
psychiatric provider the same day and subsequently seen by that provider within one week. This 
patient had already been prescribed psychotropic medications and held numerous psychiatric and 
medical diagnoses, which necessitated referral and an increased level of psychiatric care. Finally, 
the patient who scored an 18 on the PHQ-9 was immediately referred for an increased level of 
psychiatric care. This patient had been prescribed a subtherapeutic dose of antidepressant 
medication, being monitored by another provider, so a referral was more appropriate than a 
medication change. There was also a patient who scored an 8, which was below the threshold of 
10, the responses alerted the provider to possible causes of uncontrolled diabetes, and the 
frequency of monitoring was increased. 
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Table 3. Fidelity of screening 
Pre-implementation First PDSA cycle Second PDSA cycle 
# of screening 
tools 
completed 
1 15 49 
# of eligible 
patient visits 63 26 81 
% screened 1.59% 57.69% 60.49% 
Providers were encouraged to use their clinical judgment if screening was not appropriate, and 
patients were to complete the PHQ-9 voluntarily and were free to decline participation. 
Subsequently, some patients fit the screening criteria but were not screened; however, data on the 
reason for not participating was not collected. Patients with an existing diagnosis of depression 
were not removed from this project, which could skew data gathered (Levis, Benedetti, & 
Thombs, 2019). Data related to the PHQ-9 was not collected as this project looked explicitly at 
improved screening rates. Although the graduate student was available to provide educational 
sessions to providers, this was deemed unnecessary by the providers engaged in the project. 
These providers were all confident in their ability to assess for, treat, and manage or refer 
patients with depression and only required assistance with implementing the process into their 
workflow. During the project, the family physician and a part-time family nurse practitioner 
(FNP) chose not to participate and were subsequently excluded from each survey.  
The pre-implementation survey, developed by the DNP student, involved the three 
providers that participated in the second PDSA cycle of this quality improvement project. This 
survey indicated that all three providers had at least a moderate comfort level, both in using the 
PHQ-9 screening tool and managing patients with depression. Two of the three providers 
indicated not having the time to implement the depression screening protocol in either 15-minute 
or 30-minute patient visits. In free text, barriers indicated were concerns about proper 
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reimbursement and time constraints, both of which were highlighted within the literature review 
(Waitzfelder et al., 2018; Akincigil & Matthews, 2017) (Table 4).  
Table 4. Pre-implementation survey 
Provider 1 Provider 2 Provider 3 
Q1. How familiar are you with the 
Patient Health Questionnaire (PHQ-
9)? 
Somewhat familiar Very familiar Very familiar 
Q2. How likely are you to use the 
PHQ-9 screening tool for your adult 
patients to recognize the signs and 
symptoms of depression better? 
Somewhat unlikely Somewhat Likely Very likely 
Q3. How confident do you feel 






Q4. How comfortable are you with 
prescribing an antidepressant 
(SSRI's, SSNRI's, etc.) to your patient 
with mild depression? 
Very comfortable Somewhat comfortable 
Minimally 
comfortable 
Q5. Would having more information 
about depression, and possible 
treatment options make you feel 
more confident in managing a 
patient with depression? 
No Yes Yes 
Q6. What materials would you 



























Provider 1 Provider 2 Provider 3 
Q7. Would having a protocol 
established to assist you with the 
management of patients with 
positive PHQ-9 scores make you 
more comfortable? 
No Unsure Yes 
Q8. Do you know how to handle, 
based on practice protocol, a 
patient who is actively suicidal and 
an imminent risk to themselves? 
Yes Unsure Yes 
Q9. I have enough time to 
incorporate the PHQ-9 screening in 
my new patient and yearly visits 
(30-minute visits).  
FALSE FALSE TRUE 
Q10. I have enough time to 
incorporate the PHQ-9 screening in 
follow-up visits (15-minute visits). 
FALSE FALSE TRUE 
Q11. What barriers do you face that 
impact your ability to implement 
the PHQ-9? 
"Time during office 
visit, extra concerns 
created to address 
during office visit, 
coding concerns to 
get proper 
reimbursement." 
Time No response 
Q12. Do you have any comments, 
questions, or concerns that I can 
address?  
No No response No response 
The post-implementation survey, also developed by the DNP student, found contradicting 
information that indicated that all three providers had time to implement the screening protocol 
in their 30-minute visits. Additionally, two of the three providers stated that they felt comfortable 
implementing the protocol in their 15-minute appointments. In free text, two of the three 
providers continued to report that time was a barrier to screening for depression; however, one of 
these providers indicated that it would not deter the use of future screening. All three providers 
acknowledge that their satisfaction with depression screening improved, and all three stated they 
would continue to use the depression screening protocol in practice. These results were similar to 
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the findings in a cluster-randomized research study, which found that patient and provider 
satisfaction increased with the use of a decision aid and shared decision making between patient 
and provider (LeBlanc et al., 2016) (Table 5). 
Table 5. Post-implementation survey 
Provider 1 Provider 2 Provider 3 
Q1. After participating in this 
quality improvement project, how 
likely are you to continue to use the 
PHQ-9 screening tool for your adult 
patients to recognize the signs and 
symptoms of depression? 
Very Likely Somewhat likely Very likely 
Q2. After participating in this 
project, how confident do you feel 
about managing a patient with mild 
depression? 
Very confident Very confident Neutral 
Q3. After participating in this 
project, did having a step by step 
protocol of interventions for 
patients who obtained a positive 
score using the PHQ-9 screening 
tool make you feel more confident? 
No Yes Yes 
Q4. After participating in this 
project, do you still think it would 
be more beneficial to have an on-
site or on-call consultant? 
No Yes No 
Q5. Did the protocol established in 
this project increase your 
knowledge of interventions for a 
patient with a positive score using 
the PHQ-9 screening tool? 
No Unsure Yes 
Q6. After participating in this 
project, do you feel you have 
enough time to incorporate the 
PHQ-9 screening tool in visits with 
new patients and yearly physicals 
(30-minute appointments)? 
Yes Yes Yes 
Q7. After participating in this 
project, do you feel you have 
enough time to incorporate the 
PHQ-9 screening tool in 15-minute 
appointments? 
Yes No Yes 
27 
Provider 1 Provider 2 Provider 3 
Q8. After participating in this 
project, what barriers did you face 
when screening for the signs and 
symptoms of depression using the 
PHQ-9? 
"A few select 
patient reviews of 
symptoms 
increased and 
caused the office 
visit to get out of 
hand. So, I have to 
proceed knowing 
this is a risk. But it 
isinfrequent 
enough not to 








Q9. After participating in this 
project, does the protocol 
established increase your 
satisfaction with screening for 
depression in primary care?  
Yes Yes Yes 
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Figure 1: Patient Demographics: Gender 
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Figure 2: Patient Demographics: Race 
30 
Figure 3: Patient Demographics: Age 
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Figure 4: PDSA 1 Scores 
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Figure 5: PDSA 2 Scores by Provider 
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Figure 6: Percentage screened for provider one 
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Figure 7: Percentage screened for the entire project 
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CHAPTER 6: DISCUSSION 
This quality improvement project was aimed at implementing a depression screening 
protocol to assist healthcare providers with the identification of the signs and symptoms of 
depression in primary care patients. The aims of this project included improving patient 
outcomes with appropriate screening and interventions for positive PHQ-9 scores, enhanced 
screening rates to meet criteria for patient-centered medical home (PCMH), and improving 
provider satisfaction by creating a process that easily fits into the normal flow of patient care. 
The screening rate for depression using the PHQ-9 dramatically increased, and the protocol 
developed was used appropriately for every positive score above the predetermined cut off point 
of 10 or higher. Also, all three family nurse practitioners (FNP) reported increased satisfaction 
with depression screening using the implemented protocol and planned to continue its use after 
the project completed.  
The screening and handling of depression are arduous in the primary care setting. 
Researchers have previously identified that differentiating the signs and symptoms of depression 
are challenging to uncover because they may be related to an organic cause, present as comorbid 
with other complex psychiatric disorders, or comorbid with chronic medical illnesses, and can 
include acute emergencies such as suicidal ideation. This quality improvement project 
demonstrated that implementing a depression screening protocol, for new adult patients and adult 
patients attending their yearly physical appointments, provided treatment and referral options 
guided by workflow triggered by positive PHQ-9 scores. Overall, this protocol improved patient 
outcomes and provider satisfaction by quickly and easily identifying patients with signs and 
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symptoms of depression. These patients had improved outcomes based on obtaining either 
increased monitoring, treatment, or referral for a psychiatric disorder from a trusted provider. 
Provider satisfaction improved by integrating the screening protocol to increase patient screening 
and subsequently increase reimbursement. Providers were also more satisfied with the improved 
ability to provide holistic patient-centered care to their patients.   
Lippitt’s change theory and the Institute of Healthcare Improvement’s (IHI) Model of 
Improvement guided this quality improvement project by providing a framework for the 
implementation of the depression screening protocol in this primary care practice. The PDSA 
cycles were of particular importance; the first cycle provided positive results and subsequently 
provided increased buy-in from the additional providers in the office. My role as the change 
agent was to provide a combination of on-site and on-call consultation to assist if needed. 
Although there were positive scores in the moderate to severe range, a consultation was not 
utilized, as the providers were able to use the screening protocol to confidently and appropriately 
manage these patients.  
This project demonstrated to the nurse practitioners who participated, as well as those 
providers who did not participate, that implementing a screening protocol can be successfully 
done without a significant impact on their regular workflow. The positive results of this project 
have led to the nurse practitioners involved to look to expand the number of patients screened, 
which would have a more substantial impact on their entire patient population. The providers 
learned from this project that they can efficiently work to the full scope of practice as a family 
nurse practitioner and can be confident in their assessment skills, knowledge base, and time 
management skills.  
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Limitations 
There were several limitations in this quality improvement project. This project 
implemented a depression screening protocol in a primary care practice that does not accept 
Medicaid patients and is located in an affluent town in North Carolina. Practices that serve 
Medicaid patients or that are located in rural areas may face different barriers to implementation, 
decreasing the potential generalizability of this project. Stakeholder buy-in was also a limitation 
to this project, which narrowed the ability to use the depression screening protocol across the 
entire practice. Time continued to be a barrier to the providers who did implement this protocol; 
however, providers found value in using the screening protocol regardless of the time constraint. 
This project was limited by the number of patients who scored at or above the cut off value of 
10. Since there were so few positive scores, it is difficult to know if the protocol would have
continued to increase provider satisfaction if there were more positive screens and patients 
needing complex management. This primary care practice is also very well established and is 
relatively small, with the same people working day to day. It would be difficult to determine if 
the results would remain the same in a larger, less established primary care practice with more 
employees. Finally, all three providers who participated in this project already felt comfortable 
managing a patient with depression. New providers may be less comfortable with these patients 
and may be hesitant to screen for depression or might need additional education on possible 
interventions for a positive score.  
Sustainability  
The depression screening protocol developed in this quality improvement project is easily 
sustainable within the practice in which it was implemented. The PHQ-9 is a free instrument that 
is open to the public and can be printed from the internet at no cost. The practice where this 
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project took place has updated their EMR, making it easier to find the PHQ-9 screening tool to 
increase ease of documentation and to ensure proper reimbursement better. With the appropriate 
education, this depression screening protocol could be used in other primary care practices and 
could be changed to serve that patient population better. 
Future Study 
Additional research on implementing screening protocols in primary care settings is 
needed to improve overall patient healthcare nationwide. Updating electronic medical records to 
contain a section for screening tools that the practice uses, including automatic updates when 
screening should be completed, would be a beneficial next step to improve sustainability. Long-
term studies of outcomes for patients who are identified and treated for depression based on a 
screening tool result should be conducted to determine the real benefit of screening in primary 
care. The use and implementation of a screening protocol have been shown by this project to be 
quickly successful, but additional research to support the sustainability needs to be conducted to 
improve the chances of continuing to provide holistic care using screening tools in primary care. 
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CHAPTER 7: CONCLUSIONS 
 This quality improvement project has shown that implementing a depression screening 
protocol in a primary care setting can enhance patient results and improve provider satisfaction. 
The PHQ-9 screening tool is a free, reliable, and validated tool for screening for depression in 
primary care. The depression screening protocol developed in this project could be expanded in 
the current primary care practice to target a higher percentage of patients. The protocol could 
also be modified for other primary care practices and utilized to improve patient outcomes and 
provider satisfaction. Using this standardized depression screening protocol meets the 
recommendation by The U.S. Preventative Services Task Force (USPSTF), The American 
College of Physicians, The American College of Preventative Medicine, and The Institute for 
Clinical Systems Improvement (Siu & and the US Preventative Task Force (USPSTF), 2016; 
O’Conner et al., 2016; Crowley & Kirschner, 2015; Maurer, Raymond, & Davis, 2018; Trangle 
et al., 2016). Research has shown that when the signs and symptoms of depression are 
unrecognized or left untreated, MDD increases the risk of medical comorbidities such as heart 
disease, Alzheimer’s disease, stroke, obesity, and diabetes (Maurer, Raymond, & Davis, 2018). 
This protocol can also help to decrease suicide rates and to decrease overall health care spending 
(Maurer, Raymond, & Davis, 2018). Overall, the findings in this quality improvement project 
support the significance of screening for depression in primary care, and the development of a 










APPENDIX B: LIPPITT’S CHANGE THEORY 
 
 




“Assessment” “Phase 1: Recognize the issue.” 
 
“Phase 2: Assess motivation and ability to change.” 
 
“Phase 3: Assess the resources necessary for the change 
and the motivation of the change agents.” 
 
“Planning” “Phase 4: Select the objective of change.” 
 
“Phase 5: Choose a suitable role of the change agent in the 
process of change.” 
 
“Implementation” “Phase 6: Maintain change.” 
“Evaluation” “Phase 7: Terminate the helping relationship.” 












APPENDIX C: MODEL FOR IMPROVEMENT 
 









APPENDIX D: PRE-IMPLEMENTATION SURVEY 
Depression Screening in Primary Care 
 
Q1 How familiar are you with the Patient Health Questionnaire (PHQ-9)? 
 1 (1) 2 (2) 3 (3) 4 (4) 5 (5)  







Q2 How likely are you to use the PHQ-9 screening tool for your adult patients to recognize the signs and 
symptoms of depression better? 
 1 (1) 2 (2) 3 (3) 4 (4) 5 (5)  
Very likely o  o  o  o  o  






Q3 How confident do you feel about managing a patient with mild depression? 
 1 (1) 2 (2) 3 (3) 4 (4) 5 (5)  
Very 
confident o  o  o  o  o  








Q4 How comfortable are you with prescribing an antidepressant (SSRI's, SSNRI's, etc.) to your patient 
with mild depression? 
 1 (1) 2 (2) 3 (3) 4 (4) 5 (5) 6 (6) 7 (7)  
Very 
comfortable o  o  o  o  o  o  o  






Q5 Would having more information about depression, and possible treatment options make you feel 
more confident in managing a patient with depression? 
o Yes  (1) 
o No  (2) 




Q6 What materials would you prefer? (Select all that apply) 
 Pamphlet describing types of antidepressants and common side effects  (1) 
 An on-site consultant  (2) 
 An on-call consultant  (3) 






Q7 Would having a protocol established to assist you with the management of patients with positive 
PHQ-9 scores make you more comfortable? 
o Yes  (1) 
o No  (2) 




Q8 Do you know how to handle, based on practice protocol, a patient who is actively suicidal and an 
imminent risk to themselves? 
o Yes  (1) 
o No  (2) 




Q9 I have enough time to incorporate the PHQ-9 screening in my new patient and yearly physical visits 
(30-minute visits). 
o True  (1) 




Q10 I have enough time to incorporate the PHQ-9 screening in follow-up visits (15-minute visits). 
o True  (1) 




















































PHQ-9 screening for 
new patients and 
yearly physicals 
PHQ-9 score less 
than or equal to 9 
PHQ-9 score greater 




deferred to provider 








Patient positive for 
suicidality and acute 
risk to self 
initiate lab/medical 
workup to rule out 
potential medical 
causes 
Initiate medication to 
target symptoms 
Refer to mental 
health provider 
Document score and 
any intervention 
initiated 
Screen with PHQ-9 
on next visit 
Follow practice crisis 
protocol 
Document score and 
any intervention 
initiated 
Screen with PHQ-9 
on next visit 
If score is less than 
10 , continue yearly 
screening, unless 
otherwise indicated 
If score is less than 





APPENDIX G: POST-IMPLEMENTATION SURVEY 





Q1 After participating in this quality improvement project, how likely are you to continue to use the 
PHQ-9 screening tool for your adult patients to recognize the signs and symptoms of depression? 
 1 (1) 2 (2) 3 (3) 4 (4) 5 (5)  
very likely o  o  o  o  o  






Q2 After participating in this project, how confident do you feel about managing a patient with mild 
depression? 
 1 (1) 2 (2) 3 (3) 4 (4) 5 (5)  
Very 
confident o  o  o  o  o  






Q3 After participating in this project, did having a step by step protocol of interventions for patients who 
obtained a positive score using the PHQ-9 screening tool make you feel more confident? 
o Yes  (1)  
o No  (2)  






Q4 After participating in this project, do you still think it would be more beneficial to have an on-site or 
on-call consultant? 
o Yes  (1)  
o No  (2)  




Q5 Did the protocol established in this project increase your knowledge of interventions for a patient 
with a positive score using the PHQ-9 screening tool? 
o Yes  (1)  
o No  (2)  




Q6 After participating in this project, do you feel you have enough time to incorporate the PHQ-9 
screening tool in visits with new patients and yearly physicals (30-minute appointments)? 
o Yes  (1)  
o No  (2)  






Q7 After participating in this project, do you feel you have enough time to incorporate the PHQ-9 
screening tool in 15-minute appointments? 
o Yes  (1)  
o No  (2)  




Q8 After participating in this project, what barriers did you face when screening for the signs and 









Q9 After participating in this project, does the protocol established increase your satisfaction with 
screening for depression in primary care? 
o Yes  (1)  
o No  (2)  
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